Evgen Pharma Annual Loss Narrows As It Continues Phase II Trials
LONDON (Alliance News) - Clinical drug development company Evgen Pharma PLC said Wednesday its annual loss narrowed in line with expectations.Evgen, which focuses on cancer and neurological Read More